Company Analysis I-Mab
1. Summary
Advantages
- The stock's return over the last year (572.18%) is higher than the sector average (0%).
- Current debt level 1.82% is below 100% and has decreased over 5 years from 7.19%.
Disadvantages
- Price (4.63 $) is higher than fair price (2.6 $)
- Dividends (0%) are below the sector average (0.5195%).
- The company's current efficiency (ROE=-73.23%) is lower than the sector average (ROE=98.24%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| I-Mab | Healthcare | Index | |
|---|---|---|---|
| 7 days | 10.5% | 2% | 1.5% |
| 90 days | -3.9% | -42.4% | 5.1% |
| 1 year | 572.2% | 0% | 20.5% |
IMAB vs Sector: I-Mab has outperformed the "Healthcare" sector by 572.18% over the past year.
IMAB vs Market: I-Mab has outperformed the market by 551.65% over the past year.
Stable price: IMAB is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: IMAB with weekly volatility of 11% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (4.63 $) is higher than the fair price (2.6 $).
Price is higher than fair: The current price (4.63 $) is 43.8% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-1.93) is higher than that of the sector as a whole (-268.1).
P/E vs Market: The company's P/E (-1.93) is higher than that of the market as a whole (-76.8).
5.3. P/BV
P/BV vs Sector: The company's P/BV (0.3431) is lower than that of the sector as a whole (251.23).
P/BV vs Market: The company's P/BV (0.3431) is lower than that of the market as a whole (51.56).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (36.43) is lower than that of the sector as a whole (55.96).
P/S vs Market: The company's P/S indicator (36.43) is lower than that of the market as a whole (136.53).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-0.0124) is lower than that of the sector as a whole (12.23).
EV/Ebitda vs Market: The company's EV/Ebitda (-0.0124) is higher than that of the market as a whole (-47.59).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -69.69% over the last 5 years.
Accelerating profitability: The return for the last year (2.63%) exceeds the average return for 5 years (-69.69%).
Profitability vs Sector: The return for the last year (2.63%) exceeds the return for the sector (-28.07%).
6.4. ROE
ROE vs Sector: The company's ROE (-73.23%) is lower than that of the sector as a whole (98.24%).
ROE vs Market: The company's ROE (-73.23%) is lower than that of the market as a whole (-10.64%).
6.6. ROA
ROA vs Sector: The company's ROA (-55.88%) is lower than that of the sector as a whole (-5.02%).
ROA vs Market: The company's ROA (-55.88%) is lower than that of the market as a whole (39.05%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (-45.63%) is lower than that of the sector as a whole (1.2%).
ROIC vs Market: The company's ROIC (-45.63%) is lower than that of the market as a whole (8.76%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5195%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
